comparemela.com

Latest Breaking News On - Diasorin spa - Page 10 : comparemela.com

POC Diagnostics Market Size to Grow by USD 13 09 Bn, hematology diagnostics to be Largest Revenue-generating Product Segment

/PRNewswire/ The point-of-care (POC) diagnostics market size is set to grow by USD 13.09 billion from 2021 to 2026, according to Technavio. In addition, the.

United statesUnited kingdomJesse maidaAbaxis incTechnavio researchPerkinelmer incDiagnostics holdings plcChembio diagnostics incNova biomedical corpF hoffmann la roche ltdBecton dickinsonSekisui chemical coProduct serviceBrowse health care marketTrivida health incMeridian bioscience inc

POC Diagnostics Market Size to Grow by USD 13 09 Bn, hematology diagnostics to be Largest Revenue-generating Product Segment

/PRNewswire/ The point-of-care (POC) diagnostics market size is set to grow by USD 13.09 billion from 2021 to 2026, according to Technavio. In addition, the.

United statesUnited kingdomJesse maidaAbaxis incTechnavio researchPerkinelmer incDiagnostics holdings plcChembio diagnostics incNova biomedical corpF hoffmann la roche ltdBecton dickinsonSekisui chemical coProduct serviceBrowse health care marketTrivida health incMeridian bioscience inc

Stool Testing Market to Grow by USD 391 87 Mn, Gastrointestinal Tract (GI) to be Largest Revenue generating Test Segment

/PRNewswire/ The stool testing market has been segmented by test (GI and Fecal occult) and geography (North America, Asia, Europe, and ROW). By test, the GI.

United statesUnited kingdomAdvacare pharmaJesse maidaClinical genomics technologies pty ltdMckesson corpTechnavio researchGenova diagnostics incEpitope diagnostics incQuidel corpCardinal health incHologic incEiken chemical coSciences corpCenogenics corpProduct service

Stool Testing Market to Grow by USD 391 87 Mn, Gastrointestinal Tract (GI) to be Largest Revenue generating Test Segment

/PRNewswire/ The stool testing market has been segmented by test (GI and Fecal occult) and geography (North America, Asia, Europe, and ROW). By test, the GI.

United statesUnited kingdomAdvacare pharmaJesse maidaClinical genomics technologies pty ltdMckesson corpTechnavio researchGenova diagnostics incEpitope diagnostics incQuidel corpCardinal health incHologic incEiken chemical coSciences corpCenogenics corpProduct service

Sexually Transmitted Diseases (STD) Treatment Market to Record a CAGR of 4 27%, Increasing Prevalence Of STDs to Boost Market Growth

/PRNewswire/ The "Sexually Transmitted Diseases (STD) Treatment Market by Type (viral infections, bacterial infections, and other infections) and Geography.

United statesUnited kingdomCh boehringer sohnJesse maidaAurobindo pharma ltdGlaxosmithkline plcTechnavio researchInovio pharmaceuticals incGilead sciences incPfizer incAbbvie incHologic incF hoffmann la roche ltdBristol myers squibb coBecton dickinsonDynavax technologies corp

vimarsana © 2020. All Rights Reserved.